1. Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis
    Bi-Lan Li et al, 2018, J Cell Physiol CrossRef
  2. Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer
    Rongsheng Zhang et al, 2019, Cell Death Dis CrossRef
  3. The influence of microenvironment on tumor immunotherapy.
    Jieying Zhang et al, 2019, FEBS J CrossRef
  4. Crosstalk between cancer‐associated fibroblasts and immune cells in cancer
    Yuanyuan An et al, 2019, J Cell Mol Med CrossRef
  5. Targeting Natural Killer Cells for Tumor Immunotherapy.
    Cai Zhang et al, 2020, Front Immunol CrossRef
  6. The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts
    Marleen Ansems et al, 2020, Clinical and Translational Radiation Oncology CrossRef
  7. Characterization of lncRNA-Associated ceRNA Network to Reveal Potential Prognostic Biomarkers in Lung Adenocarcinoma
    Yang Wang et al, 2020, Front. Bioeng. Biotechnol. CrossRef
  8. Melanoma-associated fibroblasts impair CD8+ T cell function and modify expression of immune checkpoint regulators via increased arginase activity
    Barbara Érsek et al, 2020, Cell. Mol. Life Sci. CrossRef
  9. Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy
    Richard Barrett et al, 2020, Current Opinion in Immunology CrossRef
  10. Extracellular vesicle encapsulated microRNA-320a inhibits endometrial cancer by suppression of the HIF1α/VEGFA axis
    Na Zhang et al, 2020, Experimental Cell Research CrossRef
  11. Functional and metabolic targeting of natural killer cells to solid tumors
    Jiao Wang et al, 2020, Cell Oncol. CrossRef
  12. Natural killer cells in cancer biology and therapy
    Song-Yang Wu et al, 2020, Mol Cancer CrossRef
  13. Cancer-associated fibroblasts in therapeutic resistance of pancreatic cancer: Present situation, predicaments, and perspectives
    Xuan Han et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  14. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
    Rana Mhaidly et al, 2020, Seminars in Immunology CrossRef
  15. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy
    Richard Lee Barrett et al, 2020 CrossRef
  16. Single-Cell RNA-Seq Reveals Dynamic Change in Tumor Microenvironment During Pancreatic Ductal Adenocarcinoma Malignant Progression
    Kai Chen et al, 2020, SSRN Journal CrossRef
  17. Radiotherapy: An immune response modifier for immuno-oncology
    Mara De Martino et al, 2021, Seminars in Immunology CrossRef
  18. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression
    Kai Chen et al, 2021, EBioMedicine CrossRef
  19. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime
    De Pradip et al, 2021, IJMS CrossRef
  20. null
    Dongyoon Kim et al, 2022 CrossRef
  21. null
    Grace C. Birch et al, 2022 CrossRef
  22. Targeting CAFs to overcome anticancer therapeutic resistance
    Phei Er Saw et al, 2022, Trends in Cancer CrossRef
  23. Defining the molecular landscape of cancer-associated stroma in cutaneous squamous cell carcinoma
    Erin Beebe et al, 2022, Journal of Investigative Dermatology CrossRef
  24. Fight the Cancer, Hit the CAF!
    Andrea Papait et al, 2022, Cancers CrossRef
  25. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
    Yifei Zhu et al, 2022, Front. Endocrinol. CrossRef
  26. Cancer-associated Fibroblasts: Origin, Function, Imaging, and Therapeutic Targeting
    Rahul Rimal et al, 2022, Advanced Drug Delivery Reviews CrossRef
  27. Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies
    Liping Wang et al, 2022, Genes & Diseases CrossRef
  28. Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer
    Yanmeizhi Wu et al, 2022, Front. Pharmacol. CrossRef
  29. Modulation of the antitumor immune response by cancer-associated fibroblasts: mechanisms and targeting strategies to hamper their immunosuppressive functions
    Jerome Thiery, 2022 CrossRef
  30. NK cells and solid tumors: therapeutic potential and persisting obstacles
    Le Tong et al, 2022, Mol Cancer CrossRef